USPTO serial 86587871
VIRTUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 3, 2017
- Examiner
- WHEATLEY, TRAVIS DWIGHT
- Law office
- TMO LAW OFFICE 117
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with VIRTUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel Arbov
Daniel Arbov Cohen Tauber Speivack & Wgner P.C.420 Lexington AvenueSuite 2400New York, NY 10170Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia | ACTIVE | Oct 1, 2011 |
| 035 | Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs | ACTIVE | Oct 1, 2011 |
| 042 | Development of pharmaceutical products | ACTIVE | Oct 1, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Virtus Pharmaceuticals, LLC
- Other trademarks owned by Virtus Pharmaceuticals, LLC
- Other trademarks owned by Virtus Pharmaceuticals, LLC
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named VIRTUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 7, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 8, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 8, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 8, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 10, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 3, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 11, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 3, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 18, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 18, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 28, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 14, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 1, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 31, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 31, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 15, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 15, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2016 | ALIE | ASSIGNED TO LIE | — |
| Aug 5, 2016 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 4, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2016 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 4, 2016 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 18, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 18, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 3, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 30, 2015 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Apr 30, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 14, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 9, 2015 | NWAP | NEW APPLICATION ENTERED | — |